Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,984 | 8,759 | 10,866 | 12,796 | 14,929 |
| TOTAL | $7,300 | $9,292 | $11,373 | $12,913 | $15,150 |
| Non-Current Assets | |||||
| PPE Net | 210 | 231 | 152 | 155 | 172 |
| Other Non-Current Assets | 529 | 556 | 583 | 610 | 0 |
| TOTAL | $739 | $787 | $735 | $765 | $172 |
| Total Assets | $8,039 | $10,079 | $12,108 | $13,678 | $15,322 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 809 | 856 | 736 | 721 | 550 |
| Accrued Expenses | 964 | 1,076 | 1,098 | 703 | 1,194 |
| TOTAL | $1,880 | $2,036 | $1,936 | $1,516 | $1,744 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 411 | 438 | 465 | 500 | 0 |
| TOTAL | $411 | $438 | $465 | $500 | $N/A |
| Total Liabilities | $2,291 | $2,474 | $2,401 | $2,016 | $1,744 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27 | 4 | 4 | 4 | 4 |
| Common Shares | 1 | 3 | 3 | 2 | N/A |
| Retained earnings | -94,819 | -92,159 | -90,065 | -88,030 | -85,911 |
| TOTAL | $5,748 | $7,605 | $9,707 | $11,662 | $13,578 |
| Total Liabilities And Equity | $8,039 | $10,079 | $12,108 | $13,678 | $15,322 |